HP Helmerich & Payne
- 39.280
- +0.840+2.19%
- 39.760
- +0.480+1.22%
Helmerich & Payne News
Helmerich & Payne Is Maintained at Neutral by Piper Sandler
Helmerich & Payne Is Maintained at Neutral by Piper Sandler
Piper Sandler Maintains Neutral on Helmerich & Payne, Lowers Price Target to $39
Piper Sandler analyst Ian Macpherson maintains Helmerich & Payne (NYSE:HP) with a Neutral and lowers the price target from $44 to $39.
Helmerich & Payne Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/06/2024 1.38% Piper Sandler $44 → $39 Maintains Neutral 04/26/2024 — Benchmark Reiterates → Hold 04/26
The Five-year Underlying Earnings Growth at Helmerich & Payne (NYSE:HP) Is Promising, but the Shareholders Are Still in the Red Over That Time
Analysts' Top Energy Picks: Oneok (OKE), Helmerich & Payne (HP)
Helmerich & Payne(HP.US) Officer Sells US$398.58K in Common Stock
$Helmerich & Payne(HP.US)$ Officer Hair Cara M. sold 9,910 shares of common stock on Apr 29, 2024 at an average price of $40.22 for a total value of $398.58K.Source: Announcement What is statement of
Helmerich & Payne(HP.US) Officer Sells US$647.84K in Common Stock
$Helmerich & Payne(HP.US)$ Officer Smith Mark W. sold 16,000 shares of common stock on Apr 29, 2024 at an average price of $40.49 for a total value of $647.84K.Source: Announcement What is statement o
Helmerich & Payne Insider Sold Shares Worth $647,840, According to a Recent SEC Filing
Mark W. Smith, Senior Vice President and CFO, on April 29, 2024, sold 16,000 shares in Helmerich & Payne (HP) for $647,840. Following the Form 4 filing with the SEC, Smith has control over a total of
Helmerich & Payne, Inc. (NYSE:HP) Q2 2024 Earnings Call Transcript
Helmerich & Payne, Inc.'s (NYSE:HP) Shares Not Telling The Full Story
When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") above 17x, you may consider Helmerich & Payne, Inc. (NYSE:HP) as an attractive investment with its 11.5
Form 144 | Helmerich & Payne(HP.US) Officer Proposes to Sell 647.91K in Common Stocks
SEC FILLINGS DISCLOSED/ Apr 29, $Helmerich & Payne(HP.US)$ Officer Smith Mark W. intends to sell 16,000 shares of its common stock on Apr 29, with a total market value of approximately $647.91K. So
Form 144 | Helmerich & Payne(HP.US) Officer Proposes to Sell 398.6K in Common Stocks
SEC FILLINGS DISCLOSED/ Apr 29, $Helmerich & Payne(HP.US)$ Officer Hair Cara M. intends to sell 9,910 shares of its common stock on Apr 29, with a total market value of approximately $398.6K. Sourc
Helmerich & Payne Is Maintained at Positive by Susquehanna
Helmerich & Payne Is Maintained at Positive by Susquehanna
Susquehanna Maintains Positive on Helmerich & Payne, Lowers Price Target to $50
Susquehanna analyst Charles Minervino maintains Helmerich & Payne (NYSE:HP) with a Positive and lowers the price target from $52 to $50.
Helmerich & Payne (HP) Receives a Rating Update From a Top Analyst
Research Alert: CFRA Reiterates Hold Opinion On Shares Of Helmerich & Payne Inc.
CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We keep our 12-month target at $44, refl
Earnings Call Summary | Helmerich & Payne(HP.US) Q2 2024 Earnings Conference
The following is a summary of the Helmerich & Payne, Inc. (HP) Q2 2024 Earnings Call Transcript:Financial Performance:Helmerich & Payne reported Q2 revenues of $688 million, up from $677 million the p
What Analysts Are Saying About Helmerich & Payne Stock
In the last three months, 6 analysts have published ratings on Helmerich & Payne (NYSE:HP), offering a diverse range of perspectives from bullish to bearish.The following table provides a quick overvi
Helmerich & Payne Shares Are Trading Lower After the Company Reported Worse-than-expected Q2 Adjusted EPS Results.
Helmerich & Payne Shares Are Trading Lower After the Company Reported Worse-than-expected Q2 Adjusted EPS Results.
Benchmark: Reiterates Helmerich & Payne's (HP.US) rating.
Benchmark: Reiterates Helmerich & Payne's (HP.US) rating.
Analysis
Price Target
No Data
